---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-022800"
form_type: "8-K/A"
ticker: "OBIO"
cik: "0001814114"
company_name: "Orchestra BioMed Holdings, Inc."
filed_at: "2023-03-24T23:59:59+00:00"
generated_at: "2026-06-17T16:59:09.593360+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Orchestra BioMed reports 2022 net loss of $33.6M; revenue up to $3.5M from negative prior year

## Summary
- Net loss was $33.6M for 2022 vs $23.0M in 2021; operating expenses rose to $36.2M.
- Revenue of $3.5M included $2.9M partnership revenue; product revenue flat at $0.7M.
- Cash and marketable securities totaled $83.7M at Dec 31, 2022, up from $9.9M; funded by Series D preferred stock.
- Accumulated deficit reached $199.7M; management expects continued losses but has sufficient liquidity post-merger.
- Business combination with HSAC2 (SPAC) closed Jan 2023; audited financials now filed.

## SEC filing metadata
- accession: 0001213900-23-022800
- form_type: 8-K/A
- ticker: OBIO
- cik: 0001814114
- company_name: Orchestra BioMed Holdings, Inc.
- filed_at: 2023-03-24T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1814114/000121390023022800/0001213900-23-022800-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1814114/000121390023022800/ea175559-8ka1_orchestra.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-022800
- JSON: https://secwatch.observer/filing/0001213900-23-022800.json
- Plain text: https://secwatch.observer/filing/0001213900-23-022800.txt

## Key facts
- Earnings Releases
  Orchestra BioMed Holdings, Inc. reported financial results for the fiscal year ended December 31, 2022.
  - Period: the fiscal year ended December 31, 2022
  - Result: reported results
  source text: Item 2.02. Results of Operations and Financial Condition. The financial statements set forth under paragraph (a)(1) of Item 9.01 of this Current Report on Form 8-K are incorporated herein by reference.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1814114/000121390023022800/0001213900-23-022800-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.